BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Recruiting · NCT06538077 · Registry updated 2025-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE | Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Recruiting | Phase 4 | 2025-06-10 | NCT06538077 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Indian Council of Medical Research | 29 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 43 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| PGIMER | Chandigarh | India | 1 |